# Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia

> **NCT03431090** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Nationwide Children's Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Myelodysplasia
- Hematologic Malignancy

## Interventions

- **DEVICE:** CliniMACS® TCRαβ/CD19 Combined Depletion System

## Key facts

- **NCT ID:** NCT03431090
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-03-02
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03431090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03431090, "Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03431090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*